Drugs

Page 4 of 29

Close-up view of man in blue button-down shirt placing pills in his hand.

New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids

By Bloomberg and Gerry Smith

January 31, 2025

Pattern of colorful pills and capsules on beige background.

Cigna plans to limit out-of-pocket drug costs for U.S. patients

By Bloomberg and John Tozzi

January 30, 2025

The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.

Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next

By Lindsey Leake

January 29, 2025

Man exhales smoke while legally smoking weed with a vape pen

The truth about cannabis: Researchers from largest study on its effects on the brain have a warning for young adults

By Lindsey Leake

January 28, 2025

A person, with only the midsection visible, injects Wegovy under the skin of their stomach.

Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise

By Greg McKenna

January 24, 2025

Trump pardons founder of Silk Road, an underground website for selling drugs

Trump pardons founder of Silk Road, an underground website for selling drugs

By Chris Megerian and The Associated Press

January 22, 2025

Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By Lindsey Leake

January 22, 2025

Biden sets clemency record by commuting sentences of nearly 2,500 people convicted of nonviolent drug crimes

Biden sets clemency record by commuting sentences of nearly 2,500 people convicted of nonviolent drug crimes

By Will Weissert and The Associated Press

January 17, 2025

Close up of RFK Jr. speaking against a blue background

Health-care investors bank on Congress snarling RFK Jr.’s plans

January 17, 2025

As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic data of tens of millions of consented volunteers, health data startup Truveta announced Jan. 13, 2025.

Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers

By Lindsey Leake

January 16, 2025

Entrepreneur and Cost Plus Drugs cofounder Mark Cuban (right) speaks with Andrew Nusca, editorial director of Fortune’s Brainstorm series, at a Brainstorm Tech dinner on Monday, Jan. 6, 2025, in Las Vegas.

Mark Cuban once helped his college friend save almost $10,000 on prescriptions after a ‘horrific car accident’

By Lindsey Leake

January 7, 2025

Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1

Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1

By Jennifer Fields

January 3, 2025

Matt Gaetz speaks in front of a microphone, holding his finger up

Damning 37-page report says Matt Gaetz ‘regularly’ paid for sex and used drugs while he was a member of Congress

By Farnoush Amiri, Lisa Mascaro and The Associated Press

December 23, 2024

Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

By Lindsey Leake

December 20, 2024

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints

By Ryan Hogg and AFP

December 20, 2024

Most Popular